AIRC AIRC

PRIN 2022 PNRR PRIN 2022 PNRR

PRIN 2022 PRIN 2022

PNRR Bandi a cascata PNRR Bandi a cascata

PNRR Bandi Giovani Ricercatori YRC PNRR Bandi Giovani Ricercatori YRC

INTERREG INTERREG

HORIZON EUROPE HORIZON EUROPE

VALOStones VALOStones

DDS-MAP_Dynamic Digital Skills for Agility and Resilience in Medical and Allied Professions DDS-MAP_Dynamic Digital Skills for Agility and Resilience in Medical and Allied Professions

Finanziato da EU4HEALTH

DEFEAT-LD - Drug discovEry and repurposing to Find a trEAtmenT for Lafora Disease DEFEAT-LD - Drug discovEry and repurposing to Find a trEAtmenT for Lafora Disease

Finanziato dall’Unione europea – Next Generation EU – PNRR M6C2 - Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN.

ARISE ARISE

Finanziato da H2020 - MARIE SKLODOWSKA-CURIE ACTIONS

NECESSITY – New clinical Endpoints in primary Sjӧgren’s Syndrome: an Interventional Trial based on stratifYing patients NECESSITY – New clinical Endpoints in primary Sjӧgren’s Syndrome: an Interventional Trial based on stratifYing patients

Finanziato da H2020-Innovative Medicine Initiative 2_2017

New perspectives in proteolysis-mediated mechanism of transthyretin related amyloidosis: the role of mechanic forces New perspectives in proteolysis-mediated mechanism of transthyretin related amyloidosis: the role of mechanic forces

Finanziato da Pfizer Global Medical Grants

ARISE - African Research and Innovative Initiative for Sickle cell Education: Improving Research Capacity for Service Improvement ARISE - African Research and Innovative Initiative for Sickle cell Education: Improving Research Capacity for Service Improvement

Finanziato da Unione Europea, progetti H2020 - MARIE SKLODOWSKA-CURIE ACTIONS

Study of the amyloidogenic conversion of V30M, S52P and V122I transthyretin variants by real-time Nuclear Magnetic Resonance: elucidation of the molecular mechanisms leading to different ATTR amyloidosis severity and different drug response. Study of the amyloidogenic conversion of V30M, S52P and V122I transthyretin variants by real-time Nuclear Magnetic Resonance: elucidation of the molecular mechanisms leading to different ATTR amyloidosis severity and different drug response.

Finanziato da Fondazione Telethon, bando “Multiround 21-24 – Round 1 2022 Track Basic”